Join
Live feed
·
INSIDERFilingvia Quantisnow
Indaptus Therapeutics Inc. logo

SEC Form 4: Meckler Jeffrey A bought $51,882 worth of shares (19,727 units at $2.63), increasing direct ownership by 77% to 45,374 units

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track INDP (Indaptus Therapeutics Inc.) and more on Quantisnow.